Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

New cytokine-targeted therapies show promise for treating alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Ruxolitinib can cause a delayed skin reaction on the nose.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.